Testimonials Lead To Overbroad Claims, DDMAC Warning Letter Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Implied efficacy claims from a physician and patients for Testopel testosterone pellets, among many other problems with a series of promotional pieces, draw a warning letter to Slate Pharmaceuticals.